Position in TECH
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$63,668,305
-$3,911,971 QoQ
Shares Held
1,218,299
+6.0% QoQ
Ownership
0.778%
of shares outstanding
% of Portfolio
5.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Derivatives in TECH
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$57,486,000
PutShares
1,100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SG Capital Management LLC holds $102,571,067 across 2 Biotechnology names. TECH ranks #1 (62.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
This page
|
1,218,299 | $63,668,305 | |
| 2 | VCEL |
Vericel Corp
|
1,209,287 | $38,902,762 |
All Filings in TECH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,668,305 | 1,218,299 | Shares | Sole | 2026-05-08 | |
| 2026-03-31 | $57,486,000 | 1,100,000 | Put | Sole | 2026-05-08 | |
| 2025-12-31 | $67,580,276 | 1,149,129 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $29,405,000 | 500,000 | Put | Sole | 2026-02-13 | |
| 2024-09-30 | $221,166 | 2,767 | Shares | Sole | 2025-02-21 | |
| No filing history on record for this holder in this stock. | ||||||